EDGAR Filing Documents for 0001193125-17-383514

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-17-383514

Filing Date

2017-12-29

Accepted

2017-12-29 16:10:07

Documents

Period of Report

2017-12-27

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	d517016d6k.htm	6-K	11150
2	EX-99.1	d517016dex991.htm	EX-99.1	3646
3	EX-99.2	d517016dex992.htm	EX-99.2	14804
4	EX-99.3	d517016dex993.htm	EX-99.3	12021
5	EX-99.4	d517016dex994.htm	EX-99.4	46670
6	EX-99.5	d517016dex995.htm	EX-99.5	206264
7	GRAPHIC	g517016001.jpg	GRAPHIC	3216
8	GRAPHIC	g517016002.jpg	GRAPHIC	5675
9	GRAPHIC	g517016003.jpg	GRAPHIC	1841
	Complete submission text file	0001193125-17-383514.txt		310769

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR

Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 171282059
SIC: 2834 Pharmaceutical Preparations